REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new Proteogenomics ...
Seer, Inc. (Nasdaq: SEER), announced the launch of its new Proteograph ® Product Suite, featuring the Proteograph ONE Assay and SP200 Automation Instrument—its most advanced solution yet for scalable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results